Jin Medical International Ltd

Jin Medical International Ltd maintains a debt-to-equity ratio of 0.64, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.86, suggesting it can cover short-term obligations but with limited buffer. However, the company's free cash flow is negative at -$5.01 million, and capital expenditures are -$6.63 million, indicating significant reinvestment in operations.

The company's profitability is modest, with a return on equity of 4.02% and a return on assets of 2.23%. These figures are below the industry median for medical equipment and supplies firms, which typically report ROE and ROA in the 6-8% and 3-5% ranges, respectively. Gross profit of $6.04 million and operating income of $608,180 suggest a narrow margin structure, which may limit resilience during economic downturns.

Jin Medical International Ltd's revenue is not segmented by geography or product in the available data, but the company's total revenue of $20.69 million is concentrated in a single business line. This lack of diversification increases exposure to sector-specific risks, such as regulatory changes or supply chain disruptions.

The company's growth trajectory is uncertain, as no forward-looking revenue guidance is provided in the available data. Historical revenue figures are not available for trend analysis, but the company's operating cash flow of $2.90 million suggests some operational stability. However, the negative free cash flow and high capital expenditures indicate that the company is reinvesting heavily, which may delay near-term profitability.

The risk assessment highlights a key liquidity flag: the company has negative net cash after subtracting total debt. This suggests a potential strain on liquidity, particularly if operating cash flow does not improve. The dilution risk is assessed as low, with no near-term pressure from share issuance or convertible debt. However, the company's capital structure includes $18.84 million in long-term debt, which could become a concern if interest rates rise or credit conditions tighten.

Recent filings and transcripts are not available in the provided data, so no specific events can be cited. However, the company's financial snapshot indicates a need for close monitoring of liquidity and capital structure in the coming quarters.